CD8A and neoplasm: First, it is known that a lack of pre-existing DC activity in tumors impedes the proliferation/activation of TILs (including cytotoxic CD8 + T cells); and on the ability of RT to trigger an anti-tumor immune response and synergize with immunotherapy [18].